Arteriogenesis and Therapeutic Neovascularization |
Autore | Deindl Elisabeth |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (220 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
factor VII activating protease
HABP2 VEGF matrigel neo-vascularization hind limb ischemia angiogenesis arteriogenesis ERK endothelial cells inflammation macrophages atherosclerosis pericyte rAAV capillary microRNA isomiRs epitranscriptome neovascularization A-to-I editing m6A RNA modifications RNA methylation lower extremity arterial disease peripheral arterial disease blood flow restriction activity-based benefits training effects effect mechanism hyperoxygenation vein graft disease vascular biology spinal cord ischemia paraplegia aortic disease TAAA collateral network paraspinous compartment NO NOTCH innate immunity mast cell GH and eNOS IGF-I oxidative stress and arterial inflammation vascular homeostasis GHAS trial collateral artery growth SMC proliferation potassium channel KV1.3 KCa3.1 FGFR-1 Egr-1 PDFG-R αSM-actin TLR2/6 femoral artery ligation blood flow recovery collateral growth VHL loss of function microRNA-212/132 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557495503321 |
Deindl Elisabeth
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Cancer Immunology |
Autore | Subramanian Subree |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (316 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
NKG2D
CAR T IL-7 prostate cancer cell therapy CD19-CAR-T B cell aplasia KIR PD-1 inhibitory CAR tumor-infiltrating lymphocytes tumor microenvironment immunotherapy NK cells cancer stem cells (CSCs) antibody-dependent cellular cytotoxicity (ADCC) differentiation cytotoxicity IFN-γ osteoclasts MICA/B mAb DNA methylation RNA methylation S-adenosylmethionine (SAM) cancer innate immunity adaptive immunity T cells m6A PD-L1 resistance immune checkpoints cancer vaccine combination immunotherapy TCR diversity organ transplantation carcinoma epidemiologic studies immunosuppression CTLA-4 Treg cells immune checkpoint inhibitors CD28 antigen-presenting cells IL15 colon cancer melanoma uveal BAP1 anti-PD-1 anti-CTLA-4 TIL classical and endemic Kaposi Sarcoma systemic treatment multi-state modelling treatment free interval chemotherapy interferon triple negative breast cancer immunomodulation bispecific antibody sortase A chemo-enzymatic approach anti-CD20 antibody Fab BiFab colorectal cancer dendritic cells Atypical Chemokine Receptor 4 (ACKR4) T-cell priming immune checkpoint blockade primary liver cancer kynurenine pathway immune evasion indoleamine 2,3 dioxygenase 1 tryptophan 2,3 dioxygenase 2 IDO inhibitor antigen presenting cells |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557349203321 |
Subramanian Subree
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Epitranscriptomics: The Novel RNA Frontier |
Autore | Nigita Giovanni |
Pubbl/distr/stampa | Frontiers Media SA, 2019 |
Descrizione fisica | 1 electronic resource (127 p.) |
Collana | Frontiers Research Topics |
Soggetto topico |
Civil engineering, surveying & building
Biotechnology |
Soggetto non controllato |
Epitranscriptomics
RNA methylation Psuedourylation RNA Editing RNA |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Epitranscriptomics |
Record Nr. | UNINA-9910557235503321 |
Nigita Giovanni
![]() |
||
Frontiers Media SA, 2019 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|